ANEB
NASDAQ · Pharmaceuticals
Anebulo Pharmaceuticals Inc
$0.33
+0.01 (+3.13%)
Open$0.33
Previous Close$0.32
Day High$0.33
Day Low$0.33
52W High$2.90
52W Low—
Volume—
Avg Volume270
Market Cap12.41M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+15,048.5% upside
Current
$0.33
$0.33
Target
$49.99
$49.99
$34.23
$49.99 avg
$60.95
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.41M | 5.09M | 4.82M |
| Net Income | 1.02M | 757.9K | 675.0K |
| Profit Margin | 18.8% | 14.9% | 14.0% |
| EBITDA | 1.84M | 1.51M | 1.49M |
| Free Cash Flow | 747.3K | 835.9K | 744.4K |
| Rev Growth | +9.4% | +17.9% | +10.5% |
| Debt/Equity | 0.83 | 0.81 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |